NCT01804101 2018-05-25Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid LeukemiaFred Hutchinson Cancer CenterPhase NA Completed48 enrolled 9 charts
NCT02121418 2018-04-13Decitabine and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, or Myeloproliferative NeoplasmUniversity of WashingtonPhase NA Completed12 enrolled 10 charts